Spectroscopic, Thermodynamic and Molecular Docking Studies on Molecular Mechanisms of Drug Binding to Proteins
This reprint contains several articles where the molecular mechanisms and structural changes in target proteins on interaction with various viruses and bacteria were studied. In addition, drug-protein interactions, drug-drug interaction mechanisms, anti-Glycating, antioxidant, binding affinity, netw...
Format: | eBook |
---|---|
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
LEADER | 04436namaa2201369uu 4500 | ||
---|---|---|---|
001 | doab96629 | ||
003 | oapen | ||
005 | 20230202 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 230202s2023 xx |||||o ||| 0|eng d | ||
020 | |a 9783036562254 | ||
020 | |a 9783036562261 | ||
020 | |a books978-3-0365-6225-4 | ||
024 | 7 | |a 10.3390/books978-3-0365-6225-4 |2 doi | |
040 | |a oapen |c oapen | ||
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MKG |2 bicssc | |
720 | 1 | |a Wani, Tanveer A. |4 edt | |
720 | 1 | |a Hussain, Afzal |4 edt | |
720 | 1 | |a Hussain, Afzal |4 oth | |
720 | 1 | |a Wani, Tanveer A. |4 oth | |
720 | 1 | |a Zargar, Seema |4 edt | |
720 | 1 | |a Zargar, Seema |4 oth | |
245 | 0 | 0 | |a Spectroscopic, Thermodynamic and Molecular Docking Studies on Molecular Mechanisms of Drug Binding to Proteins |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 online resource (276 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
520 | |a This reprint contains several articles where the molecular mechanisms and structural changes in target proteins on interaction with various viruses and bacteria were studied. In addition, drug-protein interactions, drug-drug interaction mechanisms, anti-Glycating, antioxidant, binding affinity, network pharmacology-driven investigations, and targeted anticancer treatments were also investigated. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Medicine and Nursing |2 bicssc | |
650 | 7 | |a Pharmacology |2 bicssc | |
653 | |a A. aspera | ||
653 | |a advanced glycation end-products | ||
653 | |a AGEs | ||
653 | |a angiogenesis | ||
653 | |a anti-glycation | ||
653 | |a antidepressant | ||
653 | |a antioxidant | ||
653 | |a antipsychotics | ||
653 | |a binding interaction | ||
653 | |a bovine serum albumin | ||
653 | |a C. gigantea | ||
653 | |a C. procera | ||
653 | |a caffeic acid | ||
653 | |a cancer | ||
653 | |a CCL4 | ||
653 | |a charge transfer | ||
653 | |a competition | ||
653 | |a coronary artery disease | ||
653 | |a coumaric acid | ||
653 | |a deep learning | ||
653 | |a DFT | ||
653 | |a DFTs | ||
653 | |a drug design | ||
653 | |a drug repurposing | ||
653 | |a drug-protein interactions | ||
653 | |a dynamics molecular docking | ||
653 | |a ectodomain G protein | ||
653 | |a enzyme assay | ||
653 | |a erlotinib | ||
653 | |a fluorescence quenching | ||
653 | |a fluorescence spectroscopy | ||
653 | |a garlic | ||
653 | |a GC-MS | ||
653 | |a glycation | ||
653 | |a haloperidol | ||
653 | |a heparan sulfate | ||
653 | |a hepatitis E virus | ||
653 | |a HSA | ||
653 | |a human serum albumin | ||
653 | |a Huperzine A | ||
653 | |a hydrophobic interaction | ||
653 | |a keratoconus | ||
653 | |a MD simulations | ||
653 | |a methyltransferase | ||
653 | |a Minimum inhibitory concentration (MIC) | ||
653 | |a MM-GBSA calculations | ||
653 | |a MMP-2 | ||
653 | |a MMP-9 | ||
653 | |a molecular docking | ||
653 | |a Molecular docking | ||
653 | |a molecular dynamic simulation | ||
653 | |a molecular dynamics | ||
653 | |a molecular dynamics simulation | ||
653 | |a n/a | ||
653 | |a NEK7 | ||
653 | |a network pharmacology | ||
653 | |a neurodegenerative disorders | ||
653 | |a neurotoxicity | ||
653 | |a oxidative stress markers | ||
653 | |a pharmacophore mapping | ||
653 | |a phytotherapy | ||
653 | |a protein stability | ||
653 | |a protein-ligand interaction | ||
653 | |a quercetin | ||
653 | |a quetiapine | ||
653 | |a RSV | ||
653 | |a seproxetine | ||
653 | |a structural-based | ||
653 | |a thermodynamic parameters | ||
653 | |a Tuberculosis (TB) | ||
653 | |a virtual screening | ||
653 | |a VirtualToxLab | ||
653 | |a zebrafish | ||
653 | |a α-amylase | ||
653 | |a β-amyrin | ||
653 | |a π-acceptors | ||
793 | 0 | |a DOAB Library. | |
856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/96629 |7 0 |z Open Access: DOAB: description of the publication |
856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/6574 |7 0 |z Open Access: DOAB, download the publication |